PATENT CLAIM ANALYSIS

Application Number: 16044320
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["546", "268100"]

Abstract:
The invention relates to a compound of formula (I) wherein A and R 1  to R 4  are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

Claim (Index 9):
The compound according to  claim 1 , wherein the compound is selected from the group consisting of:\n 6-(4-chlorophenyl)-N-[1-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-methylpropan-2-yl]pyridine-2-carboxamide; 6-(4-chlorophenyl)-N-[2-methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)propan-2-yl]pyridine-2-carboxamide; N-[2-methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)propan-2-yl]-6-(2,2,2-trifluoroethoxy)pyridine-2-carboxamide; 6-(4-chlorophenyl)-N-[2-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]pyridine-2-carboxamide; N-[2-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]-6-(2,2,2-trifluoroethoxy)pyridine-2-carboxamide; 6-(3-chlorophenyl)-N-[2-methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)propan-2-yl]pyridine-2-carboxamide; 6-(3-chlorophenyl)-N-[1-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-2-methylpropan-2-yl]pyridine-2-carboxamide; 6-(3-chlorophenyl)-N-[2-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]pyridine-2-carboxamide; 6-chloro-5-(2,4-dichloroanilino)-N-[2-methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)propan-2-yl]pyridine-2-carboxamide; 6-(4-chlorophenyl)-5-cyclopropyl-N-[2-methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)propan-2-yl]pyridine-2-carboxamide; 6-(2-methoxyethoxy)-N-[2-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]pyridine-2-carboxamide; N-[2-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]-6-(2-oxopyrrolidin-1-yl)pyridine-2-carboxamide; 6-(3-chlorophenyl)-N-[1-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)-2-methylpropan-2-yl]pyridine-2-carboxamide; 6-(2,4-dichlorophenyl)-N-[2-(5-phenyl-1,3,4-oxadiazol-2-yl)propan-2-yl]pyridine-2-carboxamide; 6-(2,4-dichlorophenyl)-N-[2-(5-methyl-1,3,4-oxadiazol-2-yl)propan-2-yl]pyridine-2-carboxamide; 6-(cyclopropylmethoxy)-5-(3,3-difluoroazetidin-1-yl)-N-[3-[1-(2-methoxyethoxy)-2-methylpropan-2-yl]-1,2-oxazol-5-yl]pyridine-2-carboxamide; 5-cyclopropyl-6-(cyclopropylmethoxy)-N-[1-(1-hydroxy-2-methylpropan-2-yl)pyrazol-4-yl]pyridine-2-carboxamide; 5-cyclopropyl-6-(cyclopropylmethoxy)-N-[3-[1-(2-methoxyethoxy)-2-methylpropan-2-yl]-1,2-oxazol-5-yl]pyridine-2-carboxamide; 5-cyclopropyl-6-(cyclopropylmethoxy)-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]pyridine-2-carboxamide; 5-cyclopropyl-6-(cyclopropylmethoxy)-N-[3-[1-(2-ethoxyethoxy)-2-methylpropan-2-yl]-1,2-oxazol-5-yl]pyridine-2-carboxamide; 6-(cyclopropylmethoxy)-5-(3,3-difluoroazetidin-1-yl)-N-(3-hydroxy-1-adamantyl)pyridine-2-carboxamide; tert-butyl 2-[[[5-cyclopropyl-6-[(4-fluorophenyl)methyl]pyridine-2-carbonyl]amino]methyl]morpholine-4-carboxylate; (3S)-4-[5-cyclopropyl-6-(cyclopropylmethoxy)pyrazine-2-carbonyl]thiomorpholine-3-carboxamide; 5-cyclopropyl-6-(cyclopropylmethoxy)-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]pyrazine-2-carboxamide; 5-cyclopropyl-6-(cyclopropylmethoxy)-N-[3-[2-methyl -1-(oxan-2-yloxy)propan-2-yl]-1,2-oxazol-5-yl]pyrazine-2-carboxamide; N-[3-(1-azido-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-5-cyclopropyl-6-(cyclopropylmethoxy)pyrazine-2-carboxamide; 6-(Cyclopropylmethoxy)-5-(3,3-difluoroazetidin-1-yl)-N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl]pyridine-2-carboxamide; 5-Cyclopentyl-6-(cyclopropylmethoxy)-N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl]pyridine-2-carboxamide; 5-Cyclopentyl-6-(cyclopropylmethoxy)-N-[3-[1-(2-methoxyethoxy)-2-methylpropan-2-yl]-1,2-oxazol-5-yl]pyridine-2-carboxamide; and 5-Cyclopentyl-6-(cyclopropylmethoxy)-N-[3-[1-(2-ethoxyethoxy)-2-methylpropan-2-yl]-1,2-oxazol-5-yl]pyridine-2-carboxamide; or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 95.0
- Lexical Diversity: 1.51724
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14868305', '15050753', '14648418', '13486057', '15478435']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8440019517792395
- 35 USC 102 Novelty (BERT): 0.5411452808525993
- Combined Prediction Score: 0.8137162846865755
- Mean Citation Score: 374.275046
- Max Citation Score: 408.03818
- Similarity Product: 322.7147423074472

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test